Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases

Stroke

Volumn 27, Issue 10, 1996, Pages 1734-1738

  Elneihoum, A M ^a   Falke, P ^a   Axelsson, L ^a   Lundberg, E ^a   Lindgarde F ^a   Ohlsson, K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cerebral ischemia; cytokines; leukocytes

Indexed keywords

CYTOKINE; LIPOCALIN; PROTEINASE; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 0029762478     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.10.1734     Document Type: Article

References (28)

1. Prentice RL, Szatrowski TP, Kato H, Mason MW. Leukocyte counts and cerebrovascular disease. J Chronic Dis. 1982;35:703-714.
2. Belch JJF. The relationship between white blood cells and arterial disease. Curr Opin Lipidol. 1994;5:440-446.
3. Fisher TC, Meiselmann HJ. Polymorphonuclear leukocytes in ischemic vascular disease. Thromb Res. 1994;74(suppl 1):S21-S34.
4. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN. Human tumor necrosis factor: production, purification and characterization. J Biol Chem. 1985;260:2345-2354.
5. Peetre C, Thysell H, Grubb A, Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol. 1988;41:414-419.
6. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol. 1995;54:1-8.
7. Ohlsson K, Linder C, Rosengren M. Monoclonal antibodies specific for neutrophil proteinase 4: production and use for isolation of the enzyme. Biol Chem Hoppe Seyler. 1990;371:549-555.
8. Lundberg E, Bergenfeldt M, Ohlsson K. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis. Scand J Clin Lab Invest. 1991;51:23-29.
9. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatenase. J Biol Chem. 1993;268:10425-10432.
10. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human lipocalin. Scand J Clin Lab Invest. 1995;55: 577-588.
11. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
12. Harlan JM. Neutrophil-mediated vascular injury. Acta Med Scand. 1986;715(suppl):123-129.
13. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-347.
14. Bamford J. Clinical examination in diagnosis and subclassification of stroke. Lancet. 1992;339:400-405.
15. Ohlsson K, Linder C, Lundberg E, Axelsson L. Release of cytokines and proteases from human leucocytes and monocytes following phagocytosis and LPS stimulation. Scand J Clin Lab Invest. In press.
16. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci USA. 1986;83:4533-4537.
17. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA JR. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623.
18. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
19. van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood. 1990;76:2520-2526.
20. Levi M, ten-Cate H, Bauer KA, van der Poll T, Edgington T S, Büller HR, van-Deventer SJH, Hack CE, ten-Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994;93:114-120.
21. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol. 1988;11:1309-1316.
22. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 1991;22:1276-1283.
23. Vaddi K, Nicolini FA. Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon gamma by mononuclear leukoctyes in patients with ischemic heart disease: relevance in Superoxide anion generation. Circulation. 1994;90: 694-699.
24. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gök H, Özdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 1993;44:332-337.
25. Grau AJ, Berger E, Paul Sung KL, Schmid-Schönbein GW. Granulocyte adhesion, deformability, and Superoxide formation in acute stroke. Stroke. 1992;23:33-39.
26. Mercuri M, Ciuffetti G, Robinson M. Toole J. Blood cell rheology in acute cerebral infarction. Stroke. 1989;20:959-962.
27. Vermes I, Strik F. Altered leukocyte rheology in patients with chronic cerebrovascular disease. Stroke. 1988;19:631-633.
28. Collier A, Jackson M, Bell D, Patrick AW, Matthews DM, Young RJ, Clarke BF, Dawes J. Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res. 1989;10:135-138.